Neonatal drug withdrawal syndrome Completed Phase 3 Trials for Chlorpromazine (DB00477)

Also known as: Drug withdrawal syndrome neonatal / Neonatal Abstinence Syndrome / Neonatal withdrawal symptoms from maternal use of drugs of addiction / Drug withdrawal syndrome in newborn / Withdrawal syndrome neonatal / Neonatal abstinence syndrome (disorder)

IndicationStatusPhase
DBCOND0101857 (Neonatal drug withdrawal syndrome)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02810782How to Treat Opiate Withdrawal in NeonatesTreatment